Premium
Pharmacokinetics, safety and tolerance of single‐ and multiple‐dose adefovir dipivoxil in healthy Chinese subjects
Author(s) -
Sun Deqing,
Wang Haisheng,
Ni Meiyuan,
Wang Benjie,
Guo Ruichen
Publication year - 2007
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2006.02728.x
Subject(s) - adefovir , pharmacokinetics , medicine , pharmacology , immunology , chronic hepatitis , virus , lamivudine
Aims To assess the pharmacokinetics, safety and tolerance of single‐ and multiple‐dose adefovir dipivoxil (ADV) in healthy Chinese subjects. Methods Forty‐two healthy subjects were randomized into 5, 10, 20, 40 and 60‐mg dose groups for safety assessment. Nine and 10 healthy males were enrolled for a single‐dose pharmacokinetic profile and assessment of the effect of food on the pharmacokinetics of adefovir (PMEA), respectively. Another 10 healthy subjects were enrolled for a multiple‐dose safety assessment and pharmacokinetic profile. Safety and tolerance were evaluated by monitoring adverse events and laboratory parameters, and pharmacokinetics were assessed by determining PMEA concentrations with a validated LC‐MS/MS method. Results No serious adverse events occurred. The pharmacokinetic parameters of PMEA following ADV 10, 20 and 40 mg were: geometric mean [95% confidence interval (CI)] for AUC 0−24 h 227 (205, 253), 423 (361, 506) and 686 (585, 828) µg l −1 h, C max 23.0 (20.7, 27.3), 47.4 (42.8, 53.2) and 83.6 (72.6, 97.4) µg l −1 , arithmetic mean (95% CI) for t 1/2 6.8 (6.3, 7.3), 7.4 (6.7, 8.1) and 7.7 (6.5, 8.9) h, median value (range) for t max 1.00 (1.00–2.00), 0.75 (0.75–2.50) and 1.00 (0.75–2.00) h, respectively. The steady‐state pharmacokinetics parameters were similar to those following a single dose. The AUC of PMEA was unaffected by food. Conclusion ADV is safe and well tolerated in healthy Chinese subjects. The mean C max of PMEA is proportional to dose, but the linearity of AUC needs further study. There is no accumulation following multiple doses of ADV and the extent of absorption of PMEA is unaffected by food.